A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine

Makiko Nakayama, Annabelle A. Okada, Isami Hayashi, Yoshimasa Ando, Takayo Watanabe, Hiroshi Keino

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine'. Together they form a unique fingerprint.

Medicine & Life Sciences